(Q39032481)

English

A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells

scientific article published on 30 January 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Huidi Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Yan Yan

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Haixia Wen

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Xueli Jiang

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Xuefeng Cao

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Guangmei Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Guoyi Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

30 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Cell Biology International

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

631-638

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Virtual and biomolecular screening converge on a selective agonist for GPR30.

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Fos and Jun: the AP-1 connection

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

The multifaceted mechanisms of estradiol and estrogen receptor signaling.

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

GPER-1 acts as a tumor suppressor in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Expression and signaling of G protein-coupled estrogen receptor 1 (GPER) in rat sertoli cells

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

GPR30: A G protein-coupled receptor for estrogen

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

AP-1 as a regulator of cell life and death

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

GPR30 predicts poor survival for ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10243

21 January 2018

Identifiers

10.1002/CBIN.10243

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39032481&oldid=1803362676"